In particular, high frequencies (15–26%) of TRAF7 mutations has been reproducibly detected in multiple studies (284–288), and knowledge of TRAF7 mutations has contributed significantly to improving the diagnosis, classification, prognosis, and treatment of patients with meningiomas (282, 286, 289–291). This evidence concerns the gene TRAF7 and meningioma.